March issue reader poll
In vitro maturation of oocytes: Improving the odds in infertile patients
Most relevant: 25%
Somewhat relevant: 25%
Least relevant: 50%
17P: Choosing a quality compounding pharmacy
Most relevant: 75%
Somewhat relevant: 0%
Least relevant: 25%
Editorial: Newly proposed GDM screening protocol: unanswered questions remain
Most relevant: 50%
Somewhat relevant: 25%
Least relevant: 25%
Clinical Insights: SSRIs raise risk of newborn pulmonary hypertension
Most relevant: 75%
Somewhat relevant: 0%
Least relevant: 25%
Clinical Insights: Cancer survivors have poorer health behaviors
Most relevant: 25%
Somewhat relevant: 50%
Least relevant: 25%
Clinical Insights: Weight loss may prevent diabetic incontinence
Most relevant: 50%
Somewhat relevant: 25%
Least relevant: 25%
Clinical Insights: Privacy and Security Mobile Device Project launched
Most relevant: 25%
Somewhat relevant: 50%
Least relevant: 25%
Clinical Insights: Incidence of high-risk oral HPV increasing
Most relevant: 50%
Somewhat relevant: 50%
Least relevant: 0%
Clinical Insights: Caffeine and estradiol: a complicated relationship
Most relevant: 50%
Somewhat relevant: 50%
Least relevant: 0%
Clinical Insights: Noninvasive DNA test: Highly specific for fetal aneuploidy
Most relevant: 75%
Somewhat relevant: 0%
Least relevant: 25%
Clinical Insights: Cefpodoxime fails test in uncomplicated cystitis
Most relevant: 50%
Somewhat relevant: 25%
Least relevant: 25%
Clinical Insights: Maternal vitamin D linked to child’s language development
Most relevant: 0%
Somewhat relevant: 100%
Least relevant: 0%
Legally Speaking: Woman claims retained laparotomy pad caused ulcerative colitis
Most relevant: 25%
Somewhat relevant: 75%
Least relevant: 0%
Fetal Monitoring Mythbusters: Fetal heart monitoring: mild, moderate, and severe decelerations
Most relevant: 75%
Somewhat relevant: 0%
Least relevant: 25%
Protocols for High-Risk Pregnancies: Protocol 50: Preeclampsia
Most relevant: 75%
Somewhat relevant: 0%
Least relevant: 25%
FDA grants 510(k) clearance to chemiluminescence-based immunoassay
Published: January 10th 2025 | Updated: January 10th 2025The automated chemiluminescence-based immunoassay has received clearance for free testosterone, providing enhanced diagnostic options to a multitude of conditions.
Read More